title: Low molecular weight heparin given the evening before surgery compared with conventional low-dose heparin in prevention of thrombosis.
abstract: A prospective randomized double-blind trial was performed comparing conventional low-dose heparin with a low molecular weight heparin fragment for thromboprophylaxis in elective general abdominal surgical patients. The first dose of the heparin fragment was given the evening before surgery, and further doses were given thereafter every evening. There were 1002 analysable patients, 826 having received correct prophylaxis. Of these 1002 patients, 64 per cent were operated on for malignant disease. A total of 20 patients died, 10 in each group. The frequency of deep vein thrombosis was significantly reduced among patients with correct prophylaxis with the heparin fragment (9.2-5.0 per cent, P = 0.02) [corrected]. The frequency of bleeding was 6.7 per cent among the heparin fragment patients and 2.7 per cent among the patients given conventional heparin (P = 0.01), but all bleeds were of minor degree and there was no difference in the reoperation rate for bleeding, or in the transfusion requirements. Local pain at the injection site was reported significantly less often among patients given the heparin fragment.
authors.affiliation: Department of Surgery, General Hospital, Malmö, Sweden.
authors.forename: D
authors.initials: D
authors.lastname: Bergqvist
authors.forename: T
authors.initials: T
authors.lastname: Mätzsch
authors.forename: U S
authors.initials: US
authors.lastname: Burmark
authors.forename: J
authors.initials: J
authors.lastname: Frisell
authors.forename: O
authors.initials: O
authors.lastname: Guilbaud
authors.forename: T
authors.initials: T
authors.lastname: Hallböök
authors.forename: A
authors.initials: A
authors.lastname: Horn
authors.forename: A
authors.initials: A
authors.lastname: Lindhagen
authors.forename: H
authors.initials: H
authors.lastname: Ljungnér
authors.forename: K G
authors.initials: KG
authors.lastname: Ljungström
mesh_terms: D000005:Abdomen / Q000601:surgery; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D005260:Female; D006470:Hemorrhage / Q000139:chemically induced; D006493:Heparin / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D006495:Heparin, Low-Molecular-Weight / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D007431:Intraoperative Complications; D008297:Male; D008875:Middle Aged; D011183:Postoperative Complications / Q000517:prevention & control*; D011292:Premedication; D011446:Prospective Studies; D011897:Random Allocation; D013927:Thrombosis / Q000517:prevention & control*
chemical_list: D006495:Heparin, Low-Molecular-Weight; D006493:Heparin